XPOF — Xponential Fitness, Inc. Stock Price, Chart & AI Report

Negative Feb 28, 2026 • 09:08 UTC GlobeNewswire Inc. • Johnson Fistel, Pllp

Walker & Dunlop Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Walker & Dunlop announced $66.2 million in charges on February 26, 2026, resulting in earnings per share of $0.28, significantly below analyst expectations of $1.23-$1.46, causing a 25% stock decline. Similarly, Xponential Fitness stock declined over 42% on February 27, 2026. Johnson Fistel is investigating both companies for potential securities law violations on behalf of affected investors.

WD XPOF securities fraud investor losses earnings miss stock decline financial disclosures shareholder investigation

Sentiment note

Stock declined over 42% in early morning trading on February 27, 2026, following undisclosed negative financial developments, indicating significant investor losses and market concern.

Negative Apr 25, 2025 • 17:54 UTC GlobeNewswire Inc. • N/A

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Xponential Fitness, Inc. - XPOF

Xponential Fitness, Inc. (XPOF) reported an unexpected loss for Q4 2024 and a 7.7% year-over-year revenue decline, leading to a 38.45% drop in its stock price. Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by the company and its officers.

XPOF Xponential Fitness securities fraud financial restatement

Sentiment note

The company reported unexpected financial losses and a revenue decline, leading to a significant drop in its stock price. Additionally, the company's financial statements for 2023 are being restated, indicating potential issues with its financial reporting.

Negative Oct 17, 2024 • 21:49 UTC GlobeNewswire Inc. • Moore Law Pllc

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Xponential Fitness Inc. to Contact Law Firm

Moore Law PLLC is investigating potential claims against Xponential Fitness, Inc. (NYSE: XPOF) due to allegations of misleading investors about its financial health and franchisee performance.

XPOF Xponential Fitness investor claims financial health franchisee performance

Sentiment note

The article reports allegations that Xponential Fitness has issued misleading statements about its store closures, financial health of its franchisee base, and that a significant number of its franchises are unprofitable or for sale at heavily discounted prices. This suggests the company may have misled investors about its true financial condition.

Unknown Jun 26, 2024 • 15:50 UTC Zacks Investment Research • Zacks Equity Research

Xponential Fitness (XPOF) to Expand BFT Line-up in Scandinavia

Xponential Fitness (XPOF) collaborates with Tage Flugeim to mark the debut of the BFT brand in the Scandinavian region.

RCL STRA AMC XPOF

Unknown Jun 19, 2024 • 08:30 UTC Zacks Investment Research • Zacks Equity Research

Strength Seen in Six Flags (SIX): Can Its 5.8% Jump Turn into More Strength?

Six Flags (SIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SIX XPOF

Unknown Jun 18, 2024 • 13:22 UTC Zacks Investment Research • Zacks Equity Research

Xponential Fitness (XPOF) Surges 34.3%: Is This an Indication of Further Gains?

Xponential Fitness (XPOF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

XPOF CZR

Unknown Jun 17, 2024 • 20:36 UTC The Motley Fool • newsfeedback@fool.com (Jon Quast)

Why Xponential Fitness Stock Skyrocketed Today

Its founder left the company last month, but he was just replaced with a great hire.

XPOF YUM investing

Unknown May 28, 2024 • 16:33 UTC The Motley Fool • newsfeedback@fool.com (Motley Fool Staff)

A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

HIMS NVO LLY WIX investing

Unknown May 4, 2024 • 00:30 UTC Zacks Investment Research • Zacks Equity Research

Xponential Fitness (XPOF) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Xponential Fitness (XPOF) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

XPOF

Unknown May 3, 2024 • 13:30 UTC The Motley Fool • newsfeedback@fool.com (Motley Fool Transcribing)

Xponential Fitness (XPOF) Q1 2024 Earnings Call Transcript

XPOF earnings call for the period ending March 31, 2024.

XPOF earningscall-transcripts

Unknown May 2, 2024 • 22:15 UTC Zacks Investment Research • Zacks Equity Research

Xponential Fitness (XPOF) Q1 Earnings Miss Estimates

Xponential Fitness (XPOF) delivered earnings and revenue surprises of -11.11% and 0.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

XPOF TH

Unknown Apr 29, 2024 • 14:00 UTC Zacks Investment Research • Zacks Equity Research

Analysts Estimate Bowlero Corp. (BOWL) to Report a Decline in Earnings: What to Look Out for

Bowlero (BOWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BOWL XPOF